Requip 2mg Tablet contains the active ingredient Ropinirole, which belongs to a class of medications known as dopamine agonists. It is primarily prescribed for the treatment of Parkinson’s disease and restless legs syndrome (RLS). Ropinirole works by mimicking the action of dopamine, a neurotransmitter in the brain, thereby improving motor function and alleviating symptoms associated with these conditions.
Requip 2mg Tablet is indicated for the treatment of Parkinson’s disease, a progressive neurological disorder characterized by tremors, stiffness, slowness of movement, and difficulties with balance and coordination. Additionally, it is used to manage restless legs syndrome (RLS), a condition characterized by uncomfortable sensations in the legs and an irresistible urge to move them, particularly at night. Ropinirole helps reduce symptoms and enhance motor function in patients with Parkinson’s disease, as well as relieve symptoms associated with restless legs syndrome.
The dosage of Requip 2mg Tablet may vary depending on the specific condition being treated, the severity of symptoms, and individual patient response. It is typically administered orally, with or without food, as directed by a healthcare professional. The initial dosage for Parkinson’s disease is generally 0.25mg taken three times daily, with gradual dose adjustments as necessary. For restless legs syndrome, the starting dose is typically 0.25mg once daily, administered 1 to 3 hours before bedtime. Adhere strictly to the prescribed dosage regimen for optimal therapeutic outcomes.
Before initiating treatment with Requip 2mg Tablet, inform your healthcare provider about any preexisting medical conditions, allergies, or concurrent medications, particularly if there is a history of cardiovascular disorders or psychiatric conditions. Exercise caution when engaging in activities requiring mental alertness or coordination, as Ropinirole may induce dizziness or drowsiness. Avoid abrupt changes in posture to prevent the risk of orthostatic hypotension, a potential adverse effect of dopamine agonists.
Common side effects associated with Requip 2mg Tablet may include nausea, dizziness, drowsiness, headache, and hallucinations. In rare instances, it may precipitate more severe adverse effects such as orthostatic hypotension, impulse control disorders, or serotonin syndrome. Promptly notify your healthcare provider if you encounter any atypical or severe symptoms while undergoing treatment with this medication.
Requip 2mg Tablet has the potential to interact with certain medications, including antidepressants, antipsychotics, and drugs affecting dopamine levels in the brain. Notify your healthcare provider of all current medications to avoid potential drug interactions. Concomitant consumption of alcohol should be avoided, as it may exacerbate certain side effects associated with Ropinirole.
These medicines contain the same salt as Requip 2mg Tablet (Ropinirole 2mg), so they are common substitutes. Compare their prices, and change brands only after checking with your doctor or pharmacist.
| Medicine | Manufacturer | Pack | Price |
|---|---|---|---|
| Regainol 2mg Tablet | - | 10 tablets | Rs 76 |
| Ronirol Tablets 2mg | Hilton Pharma | 21 Tablets In a Pack | Rs 1,172 |
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Ronirol Tablet 0.25mg | Hilton Pharma | 0.25mg | Rs 475.20 |
| Requip 0.25mg Tablet | Glaxo Smithkline | 0.25mg | Rs 590.60 |
| Ropinol 1mg Tablet | Amarant Pharma | 1mg | Rs 789 |
| Requip 1mg Tablet | Glaxo Smithkline | 1mg | Rs 828.03 |
See all brands and prices on our Ropinirole page.
Requip 2mg Tablet contains Ropinirole, a dopamine agonist that mimics the action of dopamine in the brain. It alleviates symptoms of Parkinson’s disease and restless legs syndrome by stimulating dopamine receptors and enhancing motor function.
Requip 2mg Tablet is typically administered orally, with or without food, as directed by a healthcare professional. The specific dosage and frequency of administration may vary depending on the patient’s condition and response to treatment.
The safety of Requip 2mg Tablet during pregnancy or breastfeeding has not been established. Consult your healthcare provider before commencing treatment with this medication if you are pregnant, planning to conceive, or breastfeeding.
Yes, Requip 2mg Tablet is efficacious in managing restless legs syndrome (RLS). It mitigates symptoms such as leg discomfort and the urge to move them, particularly during nighttime.
If a dose of Requip 2mg Tablet is missed, it should be taken as soon as possible. However, if it is nearing the time for the subsequent scheduled dose, the missed dose should be omitted, and the regular dosing regimen resumed. Doubling up on doses should be avoided.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
You must be logged in to post a review.
No account yet?
Create an Account
Reviews
Clear filtersThere are no reviews yet.